On the one hand, tumor cells may act on PCs by secreting oncogenic molecules (ANGPTL4 or LAMB3 [63, 64]) to inhibit their antitumor function or promote isotype switching of protumor subtypes. The gene discussed is ANGPTL4; the disease is neoplasm.